Priming knowledge in liver
cancer across disciplines
Call for Abstracts Now Open!
Renew your membership today and enjoy
exclusive educational and networking benefits!
-
Growth patterns of hepatocellular carcinoma
NCBI, February 2020 -
Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/
Hepatology, January 2020 -
Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: A randomized, double-blind, phase III trial.
J Clin Oncol, December 2019 -
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Gut, December 2019 -
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Nature Research Journal, 2 October 2019